U.S. Justice Department: Alibaba and Alipay US to Pay $600 Million Over Illegal Drug, Chemical and Pill Press Sales Into America
The U.S. Justice Department has reached a $600 million resolution with Chinese e-commerce giant Alibaba and its U.S.-based payment processor, AUS Merchant Services, formerly known as Alipay US, over allegations that their platforms and payment systems failed to stop illegal pharmaceuticals, controlled substances, listed chemicals, and pill presses from being sold and imported into the United States. For Americans, this case should be viewed as a warning about how Chinese digital commerce platforms can become channels for dangerous products to enter U.S. communities at massive scale.
Alibaba admitted that from January 2016 through December 2024, merchants using Alibaba.com and AliExpress.com engaged in approximately 80,000 sales involving imports into the United States that included chemicals, pharmaceuticals, and pharmaceutical counterfeiting equipment in violation of federal law. The combined gross merchandise value of those transactions exceeded $200 million. Federal investigators also conducted more than 40 undercover purchases of illegal pharmaceuticals and counterfeiting equipment that could not lawfully be imported into the United States.
Those numbers matter. Eighty thousand transactions are not a handful of isolated listings that slipped past a moderator. They reveal the size of the compliance challenge created when one of China’s largest companies operates enormous online marketplaces connecting foreign sellers directly with American buyers. When illegal drugs, chemicals, and pill-making equipment can move through such platforms, the threat reaches far beyond ordinary consumer fraud. It enters the territory of public health, narcotics enforcement, counterfeit drugs, and organized crime.
The pill press issue is especially serious. Pill presses and pharmaceutical counterfeiting equipment can be used to manufacture fake tablets that resemble legitimate prescription drugs. American communities have already faced devastating consequences from counterfeit pills and illegal drug distribution. A platform that allows such equipment or dangerous pharmaceutical products to move toward the United States can help create the physical infrastructure needed by criminals to manufacture and distribute illicit drugs.
Alibaba maintained policies restricting prohibited goods, but employees raised concerns that the company’s compliance controls were inadequate. According to the Justice Department, those controls failed to prevent merchants from selling and importing illegal products. The company also provided a private in-platform messaging system that some merchants used to facilitate unlawful transactions. In certain cases, merchants directed buyers from Alibaba’s messaging service to third-party encrypted platforms to continue the deals.
That detail should concern Americans because it shows how digital marketplaces can function as the first stage of criminal commerce. A prohibited product may be advertised or discussed on a major platform, after which the seller shifts the buyer to a private or encrypted channel. Once the transaction moves away from the visible marketplace, detection becomes harder. The original platform still serves as the meeting point between criminal seller and buyer.
Alibaba also earned money connected to sellers engaged in illegal activity by charging membership, marketing, advertising, shipping, and payment-processing fees. This creates a serious compliance problem. Large marketplaces profit from activity and transaction volume, while effective enforcement against dangerous merchants may reduce both. That economic tension is exactly why voluntary policies are not enough. Companies operating at Alibaba’s scale need systems capable of identifying illegal sellers before American consumers and communities are exposed.
The payment side of the case is equally important. AUS Merchant Services, a subsidiary of Ant Group, admitted that between January 2020 and December 2023 it processed U.S. dollar payments through credit cards and wire transfers routed through U.S. bank accounts before transferring funds offshore for settlement. Its transaction-monitoring system failed to fully incorporate certain wire-transfer data, meaning it did not always identify payments involving high-risk jurisdictions or multiple payors connected to a single invoice.
AUS also admitted that its anti-money laundering compliance program failed to stop some Alibaba merchants from using its payment and settlement services to facilitate prohibited product sales into the United States. In some cases, rather than systematically restricting merchants identified as selling illegal products, AUS reported them to Alibaba. The Justice Department said that in at least one case, a merchant continued selling prohibited products to American buyers after AUS had investigated and reported the merchant.
This is where the threat becomes systemic. Illegal commerce needs more than a seller. It needs advertising, communications, payments, shipping, and settlement. Alibaba and AUS sat at crucial points in that chain. When compliance fails across both the marketplace and payment infrastructure, criminal merchants can gain access to American buyers and the U.S. financial system with far greater efficiency.
The China-related dimension should be taken seriously. Alibaba is one of China’s largest companies, while Ant Group operates one of the world’s largest digital payment ecosystems. These are not obscure websites run by unknown vendors. They are major Chinese technology and financial platforms with global reach. When weaknesses in their systems help facilitate illegal pharmaceuticals, controlled substances, listed chemicals, and pill presses entering the United States, Americans face direct consequences.
The problem is not Chinese ethnicity or ordinary Chinese merchants. The problem is the scale and structure of Chinese digital platforms that connect large numbers of foreign sellers with the American market while compliance systems fail to stop dangerous goods. The more powerful and globally integrated a platform becomes, the greater its responsibility to prevent criminal actors from exploiting its infrastructure.
Beijing often presents Chinese technology companies as victims of unfair U.S. pressure whenever American authorities impose restrictions or scrutiny. This case demonstrates why American enforcement cannot be guided by those complaints. U.S. regulators and law enforcement agencies must judge platforms by what enters the country, how transactions are processed, and whether companies have built effective controls to protect Americans.
The $600 million resolution includes a $125 million criminal monetary penalty and $200 million forfeiture for Alibaba. AUS agreed to pay an $85 million criminal monetary penalty and forfeit $190 million. Both companies accepted responsibility for the actions of their officers, directors, employees, and agents connected to the conduct described by the Justice Department. They also agreed to strengthen compliance systems and continue cooperating with future criminal investigations.
The Justice Department’s action sends an important message: foreign e-commerce and digital payment companies cannot use their size, international structure, or technological complexity as an excuse when dangerous products reach the United States. If a marketplace gives illegal sellers access to American buyers and a payment system helps move their money offshore, both sides of the transaction chain deserve scrutiny.
For Americans, the broader lesson is clear. China-related risks do not only arrive through military-linked companies, telecom equipment, cyberattacks, rare earth controls, or espionage. They can also arrive through online marketplaces where chemicals, illegal pharmaceuticals, and pill-making equipment are sold to U.S. buyers, with payments processed through American bank accounts before the funds are sent overseas.
This is a direct public-health and economic-security threat. Counterfeit pharmaceuticals can kill. Illegal chemicals can feed criminal drug production. Pill presses can support the manufacture of fake medications. Weak anti-money laundering systems can help criminal proceeds move through legitimate financial channels. When all of these vulnerabilities intersect on large Chinese-linked platforms, the United States cannot afford passive oversight.
America should continue aggressively monitoring foreign e-commerce platforms, payment processors, merchant messaging systems, and cross-border financial flows. Marketplaces must identify high-risk sellers early, remove them systematically, prevent repeat offenders from returning, and detect attempts to move transactions onto encrypted channels. Payment companies must fully analyze wire-transfer data and stop suspicious merchants before money is settled offshore.
The lesson from the Alibaba and AUS case is simple: dangerous products do not need to cross the U.S. border in a secret truck or hidden shipping container to threaten Americans. They can be ordered online, paid for through ordinary financial channels, and shipped through global commerce networks. When one of China’s largest e-commerce companies admits that approximately 80,000 illegal product sales involving the United States passed through its platforms, Americans should understand the scale of the threat.
The United States is right to demand accountability. Chinese digital platforms that profit from access to the American market must meet American safety and compliance standards. A $600 million resolution is a major consequence, but the real goal must be prevention. America should never allow Chinese e-commerce and payment infrastructure to become a convenient highway for illegal pharmaceuticals, dangerous chemicals, and pill presses into U.S. communities.
